Evidence map›Paper›PMID 29097103›Full record

Trial reportThe Journal of allergy and clinical immunology2018

Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort.

George du Toit, Peter H Sayre, Graham Roberts, Kaitie Lawson, Michelle L Sever, Henry T Bahnson, Helen R Fisher, Mary Feeney, Suzana Radulovic, Monica Basting and 3 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Dietary factors during pregnancy and atopic outcomes in childhood: A systematic review from the European Academy of Allergy and Clinical Immunology.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2020
    Pooled it
  2. Evolution of epitope-specific IgE and IgGThe Journal of allergy and clinical immunology · 2021
    Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease.The journal of allergy and clinical immunology. In practice · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. B cell receptor ligation induces IgE plasma cell elimination.The Journal of experimental medicine · 2023
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

George du ToitDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Peter H SayreDivision of Hematology-Oncology, Department of Medicine, University of California, San Francisco, Calif.
Graham RobertsUniversity of Southampton and Southampton NIHR Biomedical Research Centre, Southampton, and the David Hide Centre, Isle of Wight, United Kingdom.
Kaitie LawsonRho Federal Systems Division, Chapel Hill, NC.
Michelle L SeverRho Federal Systems Division, Chapel Hill, NC.
Henry T BahnsonImmune Tolerance Network, San Francisco, Calif.
Helen R FisherDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Mary FeeneyDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Suzana RadulovicDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Monica BastingDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Marshall PlautNational Institute of Allergy and Infectious Diseases, Bethesda, Md.
Gideon LackDepartment of Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address: Gideon.Lack@kcl.ac.uk.
Immune Tolerance Network Learning Early About Peanut Allergy study team
Guy's and St Thomas' NHS Foundation Trust · GBKing's College London · GBRho (United States) · USImmune Tolerance Network · USNational Institute of Allergy and Infectious Diseases · USUniversity of California, San Francisco · USUniversity of Southampton · GB

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
Department of HealthMedical Research Council G1000758NIAID NIH HHS HHSN272200800029CNIAID NIH HHS N01 AI015416NIAID NIH HHS UM1 AI109565NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundEarly introduction of dietary peanut in high-risk infants with severe eczema, egg allergy, or both prevented peanut allergy at 5 years of age in the Learning Early About Peanut Allergy (LEAP) study. The protective effect persisted after 12 months of avoiding peanuts in the 12-month extension of the LEAP study (LEAP-On). It is unclear whether this benefit is allergen and allergic disease specific.

objectiveWe sought to assess the effect of early introduction of peanut on the development of allergic disease, food sensitization, and aeroallergen sensitization.

methodsAsthma, eczema, and rhinoconjunctivitis were diagnosed based on clinical assessment. Reported allergic reactions and consumption of tree nuts and sesame were recorded by questionnaire. Sensitization to food allergens and aeroallergens was determined by means of skin prick testing and specific IgE measurement.

resultsA high and increasing burden of food allergen and aeroallergen sensitization and allergic disease was noted across study time points; 76% of LEAP participants had at least 1 allergic disease at 60 months of age. There were no differences in allergic disease between LEAP groups. There were small differences in sensitization and reported allergic reactions for select tree nuts, with levels being higher in the LEAP consumption group. Significant resolution of eczema and sensitization to egg and milk occurred in LEAP participants and was not affected by peanut consumption.

conclusionEarly consumption of peanut in infants at high risk of peanut allergy is allergen specific and does not prevent the development of other allergic disease, sensitization to other food allergens and aeroallergens, or reported allergic reactions to tree nuts and sesame. Furthermore, peanut consumption does not hasten the resolution of eczema or egg allergy.

Indexed as

AllergensArachisChild, PreschoolDermatitis, AtopicFemaleFood HypersensitivityHumansInfantInfant Nutritional Physiological PhenomenaMaleProtective FactorsRespiratory HypersensitivityRisk FactorsAllergensallergen-specific asthmaallergy preventionatopic dermatitiseczemaFood allergypeanut allergyrhinoconjunctivitistolerance

Identifiers

PMID29097103
PMCPMC5889963
OpenAlexW2766109557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.